Package Insert: Information for the User
Furosemide Aurovitas 40 mg Tablets EFG
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Furosemida belongs to a group of medications called diuretics, which increase the amount of urine that passes through the kidneys, helping to eliminate excess fluids from the body. Diuretic tablets are also known as “diuretics”.
Furosemida tablets are used in the treatment of edema (fluid retention) caused by heart, kidney, or liver abnormalities, alone or in combination with other antihypertensive agents. The tablets can also be used to treat pulmonary edema (fluid accumulation in the lungs) and mild to moderate hypertension (high blood pressure).
Do not take Furosemida Aurovitas:
Warnings and precautions
Consult your doctor or pharmacist before starting to take furosemide if:
In case any of the above situations occur, consult your doctor or pharmacist before taking the furosemide tablets.
Use in athletes
This medication contains furosemide, which can produce a positive result in doping control tests.
Other medications and Furosemida Aurovitas
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes over-the-counter medications, including herbal medications. This is because furosemide tablets can affect how other medications work. Some medications may also affect the functioning of furosemide.
Your doctor may need to change your dose and/or take other precautions if you are taking one of the following medications:
The following medications may affect how Furosemida Aurovitas works and increase the risk of adverse effects:
The following medications may increase the risk of adverse effects when taken with furosemide:
High doses of furosemide administered with levothyroxine may lead to an initial transient increase in free thyroid hormones, followed by a general decrease in total thyroid hormone levels.
Taking Furosemida Aurovitas with food, drinks, and alcohol
You should avoid consuming alcohol while taking Furosemida Aurovitas as it may further lower your blood pressure.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medication.
If you are pregnant or breastfeeding, consult your doctor or pharmacist for further advice before taking this medication.
Driving and operating machines
This medication may make you feel dizzy or unwell. This may occur more frequently at the start of treatment, when your doctor increases your dose, or if you consume alcohol. Do not drive or operate machinery if this occurs.
Furosemida Aurovitas contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medication.
Furosemida Aurovitas contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Adults and elderly patients
The recommended dose is 1 or 2 tablets in the morning. Your doctor will tell you how many tablets to take.
Children and adolescents (under 18 years)
If you are taking sucralfate(a medication for stomach ulcers). Do not take sucralfate at the same time as furosemide tablets. Take your dose at least 2 hours before or after furosemide because it may affect how your medication works.
If you take more Furosemida Aurovitas than you should
In case of overdose or accidental ingestion, consult your doctor immediately or go to the nearest hospital emergency department accompanied by this leaflet, or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
Carry the medication with you in its original packaging to facilitate the doctor's identification. Taking too many furosemide tablets can make you feel confused, unable to focus, lacking emotion or interest.
You may also experience dizziness, vertigo, fainting (due to decreased blood pressure), irregular heartbeats, muscle weakness or cramps, and blood clots (the signs include pain and swelling in the affected part of the body). You may also experience problems with your kidneys or blood.
If you forgot to take Furosemida Aurovitas
Take the missed dose as soon as you remember, unless it is bedtime. In that case, if you take the missed dose, you may get up at night to urinate. Take your next dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Furosemida Aurovitas
Continue taking furosemide tablets unless your doctor tells you otherwise.
Blood tests
Your doctor may perform blood tests to check that the levels of certain salts in the blood are correct.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
STOP TAKINGthis medicine and inform your doctor immediately if you experience any of the following symptoms:
The rest of the possible side effects are classified according to their frequency, in accordance with the following categories:
Frequent (may affect up to 1 in 10 patients).
Rare (may affect up to 1 in 1,000 patients).
Very rare (may affect up to 1 in 10,000 patients).
Unknown frequency (cannot be estimated from available data).
Frequent
Furosemide may cause excessive depletion of body fluids (e.g., urinating more frequently than normal) and minerals (sodium, potassium, magnesium, calcium). Symptoms that may appear are: thirst, headache, confusion, cramps, and increased muscle sensitivity, muscle weakness, heart rhythm disturbances, and gastrointestinal problems such as discomfort and stomach upset with nausea or diarrhea.
Mild increase in uric acid (hyperuricemia), possibly causing a gout attack.
Increased creatinine in the blood.
If you have low sodium (sodium deficiency):
If you have low potassium (potassium deficiency):
If you have low magnesium and calcium (magnesium and calcium deficiency):
Rare
Very rare
During furosemide treatment, blood levels of some fats (cholesterol and triglycerides) may increase, but usually return to normal in 6 months.
Unknown frequency
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging or blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy.Ask your pharmacist how to dispose of containers and medications you no longer need if you are unsure. By doing so, you will help protect the environment.
Composition ofFurosemida Aurovitas
Appearance of the product and contents of the package
White to off-white, uncoated, round tablets (8 mm in diameter), with a beveled edge and a flat surface, engraved on one face with “F” and “40” separated by a groove and flat on the other face. The tablet can be divided into equal doses.
Furosemida Aurovitas tablets are available in blister packs and HDPE bottles.
Packaging sizes:
Blister pack: 10, 20, 30, 50, 60, 90, and 100 tablets.
HDPE bottle: 30, 50, 60, 90, 100, and 500 (only for hospital use or dispensing of doses) tablets.
Only some packaging sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Responsible manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Or
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
This medicine is authorized in the member states of the European Economic Area with the following names:
Spain:Furosemida Aurovitas 40 mg tablets EFG
Netherlands:Furosemide Aurobindo 40 mg, tablets
Poland:Furosemidum Aurovitas
Portugal:Furosemida Generis Phar
Last review date of this leaflet:February 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.